Tissue banking programmes in Europe

British Medical Bulletin

Volumn 53, Issue 4, 1997, Pages 798-816

  Kalter, Eric S J ^a   De By, Theo M M H ^a  

^a Bio Implant Services Foundation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; BONE TRANSPLANTATION; CORNEA; CORNEA TRANSPLANTATION; DONOR; EUROPE; HEALTH CARE FACILITY; HEART TRANSPLANTATION; HEART VALVE; HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SCREENING; SKIN; SKIN TRANSPLANTATION; SOFT TISSUE; TISSUE PRESERVATION; TISSUE TRANSPLANTATION;

EID: 0030780917     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011649     Document Type: Review

References (66)

1. AATB. Information Alert 1996; 4: 5-8
2. Revised EAMST/EATB standards for tissue banking. 1997
3. Revised Canadian General Standard on Safety of Organs and Tissues for transplantation, 1996 (draft)
4. Medical Standards of the Eye Bank Association of America, 1995
5. Hughes JM, Jaffe HW. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Morb Mortal Wkly Rep 1994; 43: RR-8
6. Klintmalm GB. Regulation of organ donation in the United States. Chimera 1996; 8: 14-7
7. LeFor WM, McGonigle AF, Wright CE, Shires III DL. The frequency of false positive HbsHG screening test result with cadaveric tissue donors is dependent upon the assay procedure used. Tissue Cell Rep 1996; 1: 6-8
8. Novick SJ, Schrager JA, Nelson JA, Anderson ME, Baskin BL. Comparison of two hepatitis B surface antigen and two HIV-1 (p24) antigen EIA test kits with hemolyzed cadaveric blood specimens. Transplant Proc 1996; 5: 2925-26
9. Koopman-van Gemert AWMM. Hemodilution, what is right? Transplant Proc 1996; 28: 2934-6
10. Burtonboy G, Delloye C. Polymerase chain reaction in cadaveric blood and tissue. Transplant Proc 1996; 28: 2927-8
11. Colucci G. Development of polymerase chain reaction diagnostic assays for the detection and quantitation of human immunodeficiency virus and hepatitis C virus genomes. Transplant Proc 1996; 28: 2929-30
12. Zaaijer HL, van Exel-Oehlers P, Kraaijeveld T, Altena E, Lelie PN. Early detection of antibodies to HIV-1 by third generation assays. Lancet 1992; 340: 770-2
13. Simond RJ, Holmberg SD, Hurwitz RL et al. Transmission of human immunodeficiency virus type I from a seronegative organ and tissue donor. N Engl J Med 1992; 326: 726-32
14. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996; 334: 1685-90
15. Busch MP, Lee LL, Satten GA et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type I seroconversion: implications for screening of blood and tissue donors. Transfusion 1995; 35: 91-7
16. Lelie PN, Zaaijer HL, Cuypers HTM. Risk of virus transmission by tissue, blood, and plasma products. Transplant Proc 1996; 28: 2939
17. Pels E, Tullo A. European Eye Bank Activities 1991-1995. Directory of European Eye Banks, 5th Edn. 1997
18. Collaborative corneal transplantation studies research group. The collaborative corneal transplantation studies: effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol 1992; 110: 1392-403
19. D'Amaro J, Volker-Dieben H, Kruit PJ, Pels E, Lange P de, Schipper R. HLA matching and other factors in corneal transplantation: a single center experience with more than 1800 consecutive transplants in 15 years. In: Tsuji K, Aizawa M, Sasazuki T (eds). Proceedings of the 11th International Histocompatibility Workshop and Conference. Oxford: Oxford University Press, 1992; 478-82
20. Vail A, Gore SM, Bradley BA, Easty DL, Rogers CA, Armitage WJ. Influence of donor and histocompatibility factors on corneal graft outcome. Transplantation 1994; 58: 1210-6
21. Hill JC, Creemers PC. An adverse matching effect for the HLA-B locus in corneal transplantation. Transpl Int 1997: 10: 145-9
22. Volker-Dieben HJM, D'Amaro J, Kok-van Alphen CC. Hierarchy of prognostic factors for corneal allograft survival. Aust N Z J Ophthalmol 1987; 15: 11-8
23. Hopkins KA, Maguire MG, Fink NE, Bias WB. Reproducibility of HLA-A, B, and DR typing using peripheral blood samples: results of retyping in the collaborative corneal transplantation studies. Hum Immunol 1992; 33: 122-8
24. Bird AC. Pathogenesis of retinal pigment epithelial detachment in the elderly; the relevance of Bruch's membrane change. Eye 1991; 5: 1-12
25. Richard G, Weckerle P. Transplantation von Netzhautbestandteilen. Klin Monatsbl Augenheilkd 1995; 206: 71-7
26. O'Brien EA. Allograft aortic valve replacement: long term follow up. Ann Thorac Surg 1995; 60: S65-S70
27. Acar C, Farge A, Ramshevi A et al. Mitral valve replacement using cryopreserved mitral homograft. Ann Thorac Surg 1994; 57: 46-8
28. Ross D. Homograft replacement of the aortic valve. Lancet 1962; 2: 487
29. Oury JH, Eddy AC, Cleveland JC. The Ross procedure: a progress report. J Heart Valve Dis 1994; 3: 361-4
30. Ross D, Jackson M, Davies J. The pulmonary autograft - a permanent aortic valve. Eur J Cardiothorac Surg 1992; 6: 113-7
31. Barrat-Boyes BG, Roche AHG, Brandt DWT, Smith JC, Lowe JB. Aortic homograft valve replacement: a long term follow up of an initial series of 101 patients. Circulation 1969; 40: 763-5
32. Parker R. A review of heart valve banking. In: Phillips GO. ed. Advances in Tissue Banking. World Scientific, 1997; In press
33. Goffin Y, Grandmougin D, van Hoeck B. Banking cryopreserved heart valves in Europe: assessment of a 5-year operation in an international tissue bank in Brussels. Eur J Cardiothorac Surg 1996: 10: 505-12
34. Shaddy RE, Hunter DD, Osborn KA et al. Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery. Circulation 1996; 94: 1063-7
35. Szilagyi DE, Rodriguez FJ, Smith RF, Elliott JP. Late fate of arterial allografts. Arch Surg 1970; 101: 721-33
36. Kieffer E, Bahnini A, Koskas F, Ruotolo C, Le Blevec D, Plisionnier D. In situ allograft replacement of infected infrarenal aortic prosthetic grafts: results in forty-three patients. J Vasc Surg 1993; 17: 349-56
37. Vogt PR, von Segesser LK, Goffin Y, Pasic M, Turina MI. Cryopreserved arterial homografts for in situ reconstruction of mycotic aneurysms and prosthetic infection. Eur J Cardiothorac Surg 1995; 9: 502-6
38. Bové T, Demanet H, Beyens T et al. Nonvalved homografts of thoracic aorta in operation for complex cardiac disease. Ann Thorac Surg 1996; 62: 1347-50
39. O'Brien MF, McGiffin DC, Stafford EG et al. Allograft aortic valve replacement: long term comparative clinical analysis of the viable cryopreserved and antibiotic 4°C stored valves. J Cardiovasc Surg 1991; 6: 534-43
40. Noon GP, Dietrich EG, Richardson WP, De Bakey ME. Distal tibial artery bypass. Arch Surg 1969; 99: 770-5
41. Baird RJ, Tutassaura H, Miyagishima RT. Saphenous vein bypass grafts to the arteries of the ankle and foot. Ann Surg 1970; 172: 1059-63
42. Bonnaud Ph, Lebkirl B, Bondler L, Man N-K. Greffons saphènes conservés en hémodialyse. Vingt ans d'experience. Néphrologie 1994; 15: 177-80
43. Heintjes RJ, Eikelboom BC, Steijling JJF et al. The results of denaturated homologous vein grafts as conduits for secondary haemodialysis access surgery. Eur J Vasc Surg 1995; 9: 58-63
44. Reedt Dortland RWH van, Leeuwen MS van, Steijling JJF, Theodorides Th, Vroonhoven ThJMV van. Long-term results with vein homograft in femoro-distal arterial reconstructions. Eur J Vas Surg 1991; 5: 557-64
45. Idu SR, Reedt Dortland RWH van, Eikelboom BC. Results of femorotibial bypasses using venous homograft (Varivas). Proceedings 5th International Symposium of the European Homograft Bank. Brussels, 1995
46. Reedt Dortland RWH van, Schuurman H-J, Slootweg PJ, Steijling JJF, Dimitroff A, Theodorides T. Three years experience with denaturated venous homografts as an arterial substitute: A clinical, pathological and immunological study. Eur J Vasc Surg 1988; 2: 233-9
47. Tilanus HW, Obertop H, van Urk H. Saphenous vein or PTFE for femoropopliteal bypass. A prospective randomized trial. Ann Surg 1985; 202: 780-2
48. Dardik H. Long-term experience with the glutaraldehyde-stabilized human umbilical cord vein graft in lower extremity revascularization. In: Sawyer PN. ed. Modern Vascular Grafts. New York: McGraw-Hill, 1987; 153-63
49. Bang G, Urist MR. Bone induction in excavation chambers in matrix of decalcified dentin. Arch Surg 1967; 94: 781-9
50. Urist MR, Strates BS. Bone morphogenetic protein. J Dent Res 1971; 50: 1392-406
51. Glowacki J. Cellular responses to bone-derived materials. In: Friedlaender GE, Goldberg VM. eds. Bone and Cartilage Allografts. Park Ridge; American Academy of Orthopaedic Surgeons, 1991; 55-73
52. Deijkers RLM, Bloem RM, Petit PL, Brand R, Vehmeyer SBW, Veen MR. Contamination of bone allografts. J Bone Joint Surg [Br] 1997; 79: 161-6
53. Tomford WW, Doppelt SH, Mankin HJ, Friedlaender GE. Bone bank procedures. Clin Orthop 1983; 174: 15-21
54. Tomford WW. Musculoskeletal tissue banking. New York: Raven, 1993
55. 2 for bone delipidation. Biomaterials 1994; 15: 650-6
56. 2 implanted into sheep. J Mat Sci: Mat Med 1995; 6: 473-8
57. Scarborough NL, White EM, Hughes JV, Manrique AJ, Poser JW. Allograft safety: viral inactivation with bone demineralization. Contemp Orthop 1995; 31: 257-61
58. Hamer AJ, Strachan JR, Black MM, Ibbotson CJ, Stockley I, Elson RA. Biomechanical properties of cortical allograft bone using a new method of bone strength measurement. A comparison of fresh, fresh-frozen and irradiated bone. J Bone Joint Surg [Br] 1996; 78: 363-8
59. Slooff TJ, Buma P, Schreurs BW, Schimmel JW, Huiskes R, Gardeniers J. Acetabular and femoral reconstruction with impacted graft and cement. Clin Orthop 1996; 324: 108-15
60. Meeuwsen F, De Vries PhA. Preservation of human costal cartilage for transplants in nasal surgery. Proceedings 4th International Conference European Association of Tissue Banks, Leuven. 1995; 79-82
61. Mackie DP. The Euroskinbank: development and application of glycerol-preserved allografts. J Burn Care Rehabil 1996; 18: S7-S9
62. De Backere ACJ. Euro Skin Bank: large scale skin-banking in Europe based on glycerol-preservation of donor skin. Burns 1994; 20: S4-S9
63. McKay I, Woodward B, Wood K, Nasavaria HA, Hoekstra H, Green C. Reconstruction of human skin from glycerol preserved allodermis and cultured keratinocyte sheets. Burns 1994; 20: S19-S22
64. Hoekstra MJ, Kreis RW, Du Pont JS. History of the Euro Skin Bank: the innovation of preservation technologies. Burns 1994; 20: S43-S47
65. Hettich R, Ghofrani A, Hafemann B. The immunogenicity of glycerol-preserved donor skin. Burns 1994; 20: S71-S76
66. Van Baare J, Buitenwerf J, Hoekstra MJ, Du Pont JS. Virucidal effect of glycerol as used in donor skin preservation. Burns 1994; 20: S77-S80